DSM- Department of Medical Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy; IRCCS CRO Aviano-National Cancer Institute, Via Gallini 2, 33081 Aviano, Italy.
DSM- Department of Medical Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.
Gynecol Oncol. 2021 Dec;163(3):498-505. doi: 10.1016/j.ygyno.2021.09.012. Epub 2021 Oct 1.
High grade serous ovarian carcinoma (HGSOC) is the most common type of malignant ovarian neoplasm and the main cause of ovarian cancer related deaths worldwide. Although novel biomarkers such as homologous recombination deficiency testing have been implemented into the clinical decision-making algorithm since diagnosis, morphological classification and immunohistochemistry analysis are essential for diagnostic purpose. This study aims at identifying histologic and clinical features that can be predictive of patients' prognosis.
Morphological and architectural characterization including SET (Solid-Endometroid-Transitional)/Classic features was carried out in a cohort of 234 patients analyzing 695 slides. From each slide tumor infiltrating lymphocyte (TILs), the presence of necrosis, the number of mitoses, the presence of psammoma bodies, giant cells and atypical mitoses were recorded. Morphological heterogeneity was quantified by the Shannon's diversity index (SDI) considering the percentage of each architectural pattern per patient's slide.
The frequency of architectural patterns and morphological variables varied with respect of the surgical strategy (primary debulking surgery vs interval surgery after neoadjuvant chemotherapy). HGSOCs exhibiting SET features had a longer overall as well as progression free survival. Among SET features, pseudo-endometrioid and transitional like patterns had the best outcome, while it was heterogenous for solid pattern, that had better outcome for BRCA 1 negative and less heterogeneous tumors. In patients submitted to neoadjuvant chemotherapy a higher intratumor heterogeneity as defined by SDI was a negative independent prognostic factor.
A comprehensive histological examination considering architectural patterns and their heterogeneity can help in prognostication of HGSOCs.
高级别浆液性卵巢癌(HGSOC)是最常见的卵巢恶性肿瘤类型,也是全球卵巢癌相关死亡的主要原因。尽管同源重组缺陷检测等新型生物标志物已被纳入诊断后的临床决策算法,但形态学分类和免疫组织化学分析对于诊断仍然至关重要。本研究旨在确定可预测患者预后的组织学和临床特征。
对 234 例患者的 695 张切片进行形态学和结构特征分析,包括 SET(实性-子宫内膜样-过渡性)/经典特征。从每张切片中记录肿瘤浸润淋巴细胞(TILs)、坏死、有丝分裂数、砂粒体、巨细胞和非典型有丝分裂的存在情况。通过考虑每位患者切片中每种结构模式的百分比,使用香农多样性指数(SDI)量化形态学异质性。
结构模式和形态学变量的频率因手术策略(初次减瘤手术与新辅助化疗后间隔手术)而异。表现出 SET 特征的 HGSOC 具有更长的总生存期和无进展生存期。在 SET 特征中,假子宫内膜样和过渡样模式具有最佳的预后,而实性模式则存在异质性,BRCA1 阴性和异质性较小的肿瘤预后更好。在接受新辅助化疗的患者中,SDI 定义的肿瘤内异质性较高是独立的预后不良因素。
综合考虑结构模式及其异质性的组织学检查有助于预测 HGSOC 的预后。